At $7.94bn, the first quarter of 2026 fell only slightly below the $8.04bn in venture capital raised by biopharma companies in Q4 of 2025, which was the biggest quarter in years.
Venture Funding Keeps A Steady Pace In Q1
Related Posts
The EU fiscal framework undermines innovation and security
Europe’s fiscal framework was designed to discipline public borrowing. Yet shocks from the pandemic and Russia’s invasion of Ukraine have forced governments to stretch the […]
Japan Pushes Startups to Power the Next Biotech Cycle
Japan Pushes Startups to Power the Next Biotech Cycle January 3, 2026 | Saturday | Analysis | By Ayesha Siddiqui In recent years, the Japanese […]
JKTPO organises Export Awareness-cum-E-Commerce onboarding drive in Baramulla
The workshop was conducted in collaboration with the District Administration Baramulla, the ODOP Team, DPIIT, APEDA, and the Government e-Marketplace (GeM) Bandipora, Dec 26: Jammu […]